1 Department of Medicine, McGill University, Respiratory Epidemiology and Clinical Research Unit, and Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal, Quebec, Canada.
Ann Am Thorac Soc. 2014 Feb;11 Suppl 2:S112-7. doi: 10.1513/AnnalsATS.201309-327RM.
Research in respiratory, sleep, and critical care medicine has historically been the domain of scientists and clinicians attempting to understand pathophysiological mechanisms and consequences of disease in an effort to develop effective treatments. This traditional approach of placing scientific rigor before the patient's reality is changing. There is growing recognition of the importance of integrating patient perspectives (e.g., preferences, expectations, and expanded definitions of what constitutes "successful" outcomes) into clinical research to achieve meaningful results for a broader group of stakeholders. This evolution is reflected in the growth of patient-centered organizations and patient advocacy groups that seek to meaningfully integrate patients into the process of prioritizing research needs and creating alliances wherein patients and researchers can partner together to accomplish research goals. In tandem, a growing number of real-world trials (i.e., those with broader, more representative patient populations and routine care pathways) now complement findings from traditional randomized controlled trials and offer new opportunities to design studies that better reflect patients' healthcare preferences and experiences. Patients' perspectives are key determinants of treatment adherence and outcomes, as well as the feasibility and likely value of implementing care pathways. The advent of smartphone and push technologies offer new opportunities for the collection of more patient-centered and ecologically valid patient data, thereby adding new dimensions to meaningfully integrate patients into real-world research.
呼吸、睡眠和危重病医学领域的研究历史上一直是科学家和临床医生的领域,他们试图了解疾病的病理生理机制和后果,以努力开发有效的治疗方法。这种将科学严谨性置于患者现实之前的传统方法正在发生变化。越来越多的人认识到将患者视角(例如偏好、期望和对“成功”结果的扩展定义)纳入临床研究的重要性,以便为更广泛的利益相关者实现有意义的结果。这种演变反映在以患者为中心的组织和患者倡导团体的增长中,这些组织和团体试图将患者有意义地纳入确定研究需求和建立联盟的过程中,使患者和研究人员能够合作实现研究目标。与此同时,越来越多的真实世界试验(即具有更广泛、更具代表性的患者人群和常规护理途径的试验)现在补充了传统随机对照试验的发现,并为设计更好地反映患者医疗保健偏好和体验的研究提供了新的机会。患者的观点是治疗依从性和结果的关键决定因素,也是实施护理途径的可行性和可能价值的关键决定因素。智能手机和推送技术的出现为更以患者为中心和更具生态有效性的患者数据收集提供了新的机会,从而为将患者有意义地纳入真实世界研究增加了新的维度。